Rituximab in Refractory Ophthalmic Wegener's Granulomatosis PR3 Titers May Predict Relapse, But Repeat Treatment Can Be Effective

L Joshi; SL Lightman; AD Salama; AL Shirodkar; CD Pusey; SRJ Taylor

doi:10.1016/j.ophtha.2011.06.009

$Rituximab in Refractory Ophthalmic Wegener's Granulomatosis PR3 Titers May Predict Relapse, But Repeat Treatment Can Be Effective$

Journal article

Peer reviewed

Rituximab in Refractory Ophthalmic Wegener's Granulomatosis PR3 Titers May Predict Relapse, But Repeat Treatment Can Be Effective

L Joshi, SL Lightman, AD Salama, AL Shirodkar, CD Pusey and SRJ Taylor

OPHTHALMOLOGY, Vol.118(12), pp.2498-2503

01/12/2011

DOI: https://doi.org/10.1016/j.ophtha.2011.06.009

Abstract

Science & Technology

Life Sciences & Biomedicine

Ophthalmology

OPHTHALMOLOGY

ANTIBODY-ASSOCIATED VASCULITIS

RHEUMATOID-ARTHRITIS

MYCOPHENOLATE-MOFETIL

LYMPHOCYTE DEPLETION

OPEN-LABEL

THERAPY

TRIAL

CYCLOPHOSPHAMIDE

SCLEROSIS

DISEASE

Files and links (1)

url

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000298138000029&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202View

Author

Metrics

23 Record Views

36 Times Cited - Web of Science

Details

Title: Rituximab in Refractory Ophthalmic Wegener's Granulomatosis PR3 Titers May Predict Relapse, But Repeat Treatment Can Be Effective
Creators: L Joshi
SL Lightman
AD Salama
AL Shirodkar
CD Pusey
SRJ Taylor
Publication Details: OPHTHALMOLOGY, Vol.118(12), pp.2498-2503
Publisher: ELSEVIER SCIENCE INC
Date published: 01/12/2011
Date submitted: 17/05/2017
Identifiers: 99511738202346
Academic Unit: University of Surrey
Resource Type: Journal article

Rituximab in Refractory Ophthalmic Wegener's Granulomatosis PR3 Titers May Predict Relapse, But Repeat Treatment Can Be Effective

Abstract

Files and links (1)

Metrics

Details

Usage Policy